Abbvie Endocrine Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE, and what generic alternatives to ABBVIE ENDOCRINE drugs are available?
ABBVIE ENDOCRINE has seven approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE drugs in twenty-eight countries.
Summary for Abbvie Endocrine
| International Patents: | 35 |
| US Patents: | 2 |
| Tradenames: | 4 |
| Ingredients: | 2 |
| NDAs: | 7 |
Drugs and US Patents for Abbvie Endocrine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-007 | Aug 15, 2011 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-005 | Jan 21, 1994 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-002 | Oct 26, 1995 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 019010-001 | Apr 9, 1985 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-004 | Apr 16, 1993 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbvie Endocrine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-008 | Aug 15, 2011 | 5,631,020 | ⤷ Subscribe |
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-002 | May 30, 1997 | 5,643,607 | ⤷ Subscribe |
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | 5,631,020 | ⤷ Subscribe |
| Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-004 | Apr 16, 1993 | 5,631,020 | ⤷ Subscribe |
| Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | 5,631,021 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Abbvie Endocrine Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 200970600 | ⤷ Subscribe |
| Eurasian Patent Organization | 016176 | ⤷ Subscribe |
| Brazil | PI0720582 | ⤷ Subscribe |
| Israel | 198845 | ⤷ Subscribe |
| Dominican Republic | P2009000144 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
